top of page
Amit Nathwani
UCL, London
Professor Amit Nathwani is a Senior NIHR Investigator, Professor of Haematology at UCL and Founder and CEO, NovalGen Therapeutics. His research extends to a diverse range of translational gene transfer approaches focused on inherited disorders such as haemophilia A and B, Congenital FVII deficiency, Fabry's and Gaucher's disease. Prof. Nathwani is the recipient of the Ham Wasserman Award, ESGCT Outstanding Achievement Award amongst others.
bottom of page